A detailed history of Jpmorgan Chase & CO transactions in Ultralife Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13,529 shares of ULBI stock, worth $117,837. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,529
Previous 19,310 29.94%
Holding current value
$117,837
Previous $170,000 15.88%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$8.41 - $13.25 $48,618 - $76,598
-5,781 Reduced 29.94%
13,529 $143,000
Q1 2024

May 10, 2024

SELL
$6.48 - $9.79 $304,333 - $459,787
-46,965 Reduced 70.86%
19,310 $170,000
Q4 2023

Feb 12, 2024

BUY
$6.68 - $11.37 $172,350 - $293,357
25,801 Added 63.75%
66,275 $451,000
Q3 2023

Nov 14, 2023

BUY
$4.85 - $10.43 $196,231 - $421,997
40,460 Added 289000.0%
40,474 $395,000
Q4 2021

Feb 10, 2022

SELL
$5.1 - $7.15 $2,723 - $3,818
-534 Reduced 97.45%
14 $0
Q3 2021

Nov 12, 2021

BUY
$7.08 - $8.6 $3,879 - $4,712
548 New
548 $4,000

Others Institutions Holding ULBI

About ULTRALIFE CORP


  • Ticker ULBI
  • Exchange NASDAQ
  • Sector Industrials
  • Industry Electrical Equipment & Parts
  • Shares Outstandng 16,133,600
  • Market Cap $141M
  • Description
  • Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithiu...
More about ULBI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.